Navigation Links
Global Diabetes Drugs Market 2011-2015

NEW YORK, Nov. 14, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:


Global Diabetes Drugs Market 2011-2015


TechNavio's analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs market has also been witnessing the trend of increasing awareness and education. However, the increasing use of complementary and alternative medicine (CAM) could pose a challenge to the growth of this market.


TechNavio's report, the Global Diabetes Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Diabetes Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors dominating this space include Eli Lilly and Co., Merck and Co. Inc., Novo Nordisk A/S and Sanofi S.A.


Key questions answered in this report:

What will the market size be in 2015 and at what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.


TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.




01. Executive Summary

02. Introduction

03. Market Coverage

Market Overview

Key Offerings

04. Market Landscape

04.1 Global Diabetes Drugs Market

Market Size

04.2 Available Drug Classes for Diabetes

04.3 Share of DPP4 Drugs in BRIC Countries in 2011





Consolidated Share of DPP4 Drugs in BRIC Countries in 2011

04.4 Share of DPP4 Drugs in European Countries in 2011






Consolidated Share of DPP4 Drugs in European Countries in 2011

04.5 Five Forces Analysis

05. Geographical Segmentation

06. Rate of Incidence and Prevalence

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

14.1 Novo Nordisk A/S

Business Overview

SWOT Analysis

14.2 Merck and Co., Inc.

Business Overview

SWOT Analysis

14.3 Bristol-Myers Squibb Co.

Business Overview

SWOT Analysis

14.4 Sanofi S.A.

Business Overview

SWOT Analysis

15. Other Reports in this Series


List of Exhibits:

Exhibit 1: Global Diabetes Drugs Market 2011-2015 (US$ million)

Exhibit 2: Global Diabetes Drugs Market by Route of Administration

Exhibit 3: Global Diabetes Drugs Market by Geographical Segmentation 2011

Exhibit 4: Global Diabetes Drugs Market by Vendor Segmentation 2011




To order this report:

Drug_and_Medication Industry: Global Diabetes Drugs Market 2011-2015

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
2. Global Home Healthcare Equipment Market 2011-2015
3. Global Laparoscopic Devices Market 2011-2015
4. Global Drugs of Abuse Testing Market 2011-2015
5. Global Tuberculosis Drugs Market 2011-2015
6. Henry Schein To Present At The Jefferies 2012 Global Healthcare Conference
7. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
8. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
9. Eminent Members of Global and Indian Community to Celebrate Rolex Awards at Gala New Delhi Ceremony
10. Zimmer Launches Smartphone Comeback App Globally
11. Unilifes Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
Post Your Comments:
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... meeting of shareholders held today, the Company,s shareholders voted ... the previously announced agreement and plan of merger (the ...
(Date:11/24/2015)... , Nov. 24, 2015  In the pharmaceutical ... in an effort to quickly uncover new insights, tactics ... --> --> However, organizations ... market research project and ensure that all rules and ... industry standards. Another major barrier to efficiently launching market ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... AL (PRWEB) , ... November 24, 2015 , ... American ... announced today the opening of a holiday pop-up clinic located in Metro Atlanta’s North ... needs in a new and different way. The location is scheduled to operate through ...
Breaking Medicine News(10 mins):